BRIEF-Acelyrin Determines Unsolicited Indication Of Interest From Concentra Biosciences Not Reasonably Expected To Result In A Superior Proposal To Planned Alumis Merger
Mar 4, 2025 6:33 AM
March 4 (Reuters) - Alumis Inc ( ALMS ):
* ACELYRIN DETERMINES UNSOLICITED INDICATION OF INTEREST
FROM
CONCENTRA BIOSCIENCES NOT REASONABLY EXPECTED TO RESULT IN A
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations,
you may see comments from our Community Managers.